2020 - 2021

 

May 24, 2021 - The COVID-19 Pandemic: Challenges and Opportunities for Cell Processing Facilities

In this extended web seminar (running 1.5 hours), we will focus on the impacts in the cell therapy community and specifically on cell processing facilities as they navigate the ‘new normal’. The pandemic’s impact includes the plethora of clinical trials and networks that have started rapidly in the field of cell therapy and regulatory pathways have also been fast-forwarded in previously unimaginable ways. Cell therapy facilities manufacturing these products have experienced unprecedented manufacturing and operations issues as a result of the pandemic. An overview of the change in the clinical cell therapy landscape, as well as how manufacturing facilities have managed and continue to troubleshoot operations in these conditions will be discussed.  The speakers are from two of the PACT Cell Processing Facilities and the the presentation will be followed by an extended Question and Answer Session which will include representatives from all five of the PACT Cell Processing Facilities.

Speakers:

  • COVID-19/SARS-Cov-2 – Role of Cell-based Therapy | Joshua Hare, MD, FACC, FAHA
    (Louis Lemberg Professor of Medicine and Founding Director, Interdisciplinary Stem Cell Institute, Miller School of Medicine at the University of Miami)
  • COVID-19 Impacts on GMP Facilities: Preparing for Apocalypse 2.0 | Joseph Gold, PhD
    (Senior Director of Manufacturing, Center for Biomedicine & Genetics, City of Hope)

Save the date flyer
Activity Accreditation Statement Sheet
Web Seminar Handouts (will be posted the day of the web seminar)
Web Seminar Audio File (will be posted after the web seminar)

 

Prior Web Seminars

December 15, 2020 - Contract Manufacturing By and For Academic Institutes

In this webinar we will review how academic institutions are operationalizing their resources to offer contract manufacturing. We will also cover outsourcing of manufacturing and testing by academic institutions. The personalized nature of cellular therapy products introduces a detailed and scientific development. Academic institutes are well-equipped to develop products with scientific oversight. Their involvement also helps to accelerate their institutional ideology in furthering the growth and evolution of the field of cell therapy.

Speakers:

 

September 3, 2020 - Methods for Cellular Therapies: Tracking Cells In Vivo and Assessing Biodistribution in Patients -- What are your cells doing? Where do they go?

Speakers:

 

 

July 17, 2020 - Cell Therapy GTP and GMP Facilities: Design and Operation to Optimize Space to Meet Manufacturing Needs

Speakers:

Vertical Tabs

This page is associated with a larger collection of pages. You can view them as a whole here.